
Biomiic offers fast, accurate microbiome sequencing and biomarker discovery in plain, consumer-accessible language. The company combines high-throughput shotgun metagenomic sequencing with AI-driven analysis to detect bacterial and viral genomic signatures and discover next-generation biomarkers. It operates as a sequencing service and AI platform focused on microbiome diagnostics and biomarker discovery, serving consumer and research customers. Biomiic produces high-dimensional, high-coverage genomic profiles usable for research, clinical studies, and personalized reporting.

Biomiic offers fast, accurate microbiome sequencing and biomarker discovery in plain, consumer-accessible language. The company combines high-throughput shotgun metagenomic sequencing with AI-driven analysis to detect bacterial and viral genomic signatures and discover next-generation biomarkers. It operates as a sequencing service and AI platform focused on microbiome diagnostics and biomarker discovery, serving consumer and research customers. Biomiic produces high-dimensional, high-coverage genomic profiles usable for research, clinical studies, and personalized reporting.
Core offering: High-throughput shotgun metagenomic sequencing plus AI-driven microbiome analysis and biomarker discovery
Customers: Consumer and research customers (sequencing service and AI platform)
Founded: 2015
Known investor: SGH CAPITAL
Notable funding event: $100,000 convertible note (Oct 1, 2015)
Microbiome diagnostics and biomarker discovery
2015
DeepTech
$100,000
“SGH CAPITAL participation via a $100,000 convertible note”